15 results
8-K
EX-99.2
VANI
Vivani Medical Inc
8 Feb 22
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
12:00am
50% of patients do not meet glycemic targets primarily due to adherence NPM - 119 Can Enable Guaranteed Adherence Curtis et al. 2017. *See reference
425
EX-99.2
VANI
Vivani Medical Inc
8 Feb 22
Business combination disclosure
12:00am
50% of patients do not meet glycemic targets primarily due to adherence NPM - 119 Can Enable Guaranteed Adherence Curtis et al. 2017. *See reference
FWP
VANI
Vivani Medical Inc
6 Oct 14
Free writing prospectus
12:00am
targets 200 - 300 centers globally) Manufacturing Scalability Current facility can accommodate annual production of ~1200 units/year Product cost
8-K
EX-99.1
VANI
Vivani Medical Inc
23 Sep 22
Regulation FD Disclosure
6:04am
and injectables do not guarantee adherence Approximately 50% of patients do not meet glycemic targets primarily due to adherence NPM - 119 Designed
8-K
EX-99.1
VANI
Vivani Medical Inc
15 May 23
Results of Operations and Financial Condition
6:49am
targets primarily due to adherence NPM - 119 Designed to Enable 100% Adherence through Implant Duration Dual Incentive to Adopt Technology that Improves
8-K
EX-99.1
n75mtdlzqi3
17 Oct 22
Regulation FD Disclosure
6:45am
8-K
EX-99.2
2ctdb00shlpz
6 Jan 21
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
6:14am
DEFA14A
EX-99.2
g81nu3ei
6 Jan 21
Additional proxy soliciting materials
6:12am
8-K
EX-99.1
a2cho5jqd1 6l
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.1
kr9un8qnma2fni63t
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
gcwdtbbhd1usij6
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.2
cooea0
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
e77xv8bp
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
10-K
1xzgdyk v6vx
17 Mar 15
Annual report
12:00am
424B3
c99sgj3yrjs95kuubnv8
20 Nov 14
Prospectus supplement
12:00am
- Prev
- 1
- Next